Vancomycin Dosing for Serious MRSA Infections

Standard Dosing Regimen

For serious MRSA infections in adults with normal renal function, vancomycin should be dosed at 15-20 mg/kg (actual body weight) every 8-12 hours, not exceeding 2 g per dose, as recommended by the Infectious Diseases Society of America 1, 2
Traditional fixed doses of 1 g every 12 hours are inadequate for most patients and fail to achieve therapeutic trough concentrations of 15-20 μg/mL required for serious infections, according to the Clinical Infectious Diseases guidelines 1
Weight-based dosing is critical, particularly in obese patients who are systematically underdosed with conventional 1 g every 12 hour regimens, as stated by the Praxis Medical Insights 2, 3

A loading dose of 25-30 mg/kg (actual body weight) should be administered to seriously ill patients with sepsis, meningitis, pneumonia, or infective endocarditis to rapidly achieve therapeutic concentrations, as recommended by the Clinical Infectious Diseases and Praxis Medical Insights guidelines 1, 2, 3
Critically ill patients have expanded volumes of distribution due to fluid resuscitation, requiring higher loading doses to achieve early therapeutic levels, according to the Praxis Medical Insights 2, 3
The loading dose is NOT affected by renal function and should be given regardless of creatinine clearance, as stated by the Praxis Medical Insights 3

Target trough concentrations of 15-20 μg/mL for serious infections such as bacteremia, endocarditis, meningitis, pneumonia, and osteomyelitis, as recommended by the Clinical Infectious Diseases and Praxis Medical Insights guidelines 1, 2, 3
Obtain trough levels before the fourth or fifth dose at steady state, according to the Praxis Medical Insights 2, 3
The optimal pharmacodynamic target is an AUC/MIC ratio >400, which correlates with clinical efficacy, as stated by the Praxis Medical Insights 2, 3

For isolates with vancomycin MIC >2 μg/mL (VISA or VRSA), switch to an alternative agent immediately, as recommended by the Clinical Infectious Diseases and Praxis Medical Insights guidelines 1, 2, 3
When MIC <2 μg/mL, clinical response should guide continued vancomycin use regardless of the specific MIC value, according to the Clinical Infectious Diseases and Praxis Medical Insights guidelines 1, 2
Alternative agents for MIC >2 μg/mL include daptomycin, linezolid, or ceftaroline, as stated by the Praxis Medical Insights 3

For persistent MRSA bacteremia or vancomycin treatment failures, use high-dose daptomycin (10 mg/kg/day) in combination with another agent after ensuring adequate source control, as recommended by the Clinical Infectious Diseases and Praxis Medical Insights guidelines 1, 2
First, perform surgical debridement and remove all foci of infection, according to the Clinical Infectious Diseases guidelines 1
Combination options include gentamicin (1 mg/kg IV every 8 hours), rifampin (600 mg daily or 300-450 mg twice daily), linezolid (600 mg twice daily), or TMP-SMX (5 mg/kg twice daily), as stated by the Clinical Infectious Diseases and Praxis Medical Insights guidelines 1, 2